Cti Biopharma reported $74.82M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Applied Genetic Technologies AGTC:US $ 109.71M 3.32M
Baxter International BAX:US $ 8004M 148M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Cti Biopharma CTIC:US $ 74.82M 35.47M
Cytori Therapeutics CYTX:US $ 18M 2.55M
Eli Lilly And LLY:US $ 17295.5M 691M
Geron GERN:US $ 201.76M 13.5M
Mirati Therapeutics MRTX:US $ 1278.09M 25.42M
Northwest Biotherapeutics NWBO:US 8.35M 4.87M
Novartis NOVN:VX 23.81B 1.61B
Novartis NVS:US $ 23808M 1610M
Seattle Genetics SGEN:US $ 3098.51M 5.18M
Sunesis Pharmaceuticals SNSS:US $ 125.14M 7.16M
Teva Pharmaceutical Industries TEVA:US $ 12822M 421M
YTE INCY:US $ 2620.06M 170.09M